- Healthcare Research - Healthcare Research Fri, 18 Jan 2019 17:56:30 Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023 Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluctuations. However, as the industry matures, companies are innovating across instrument technology, reagents, and software solutions in order to maintain a competitive edge. As leading markets such as the United States and Europe face cost pressures, companies are offering solutions around multiplexing and high throughput devices. Reagent manufacturers are focused on products that allow for high speed, efficacy, lower processing cost, reliable repeatability/consistency, sensitivity, and multiplexing capabilities. They are increasingly focusing on novel applications in oncology, infectious diseases, aging related diseases, as well as applied sciences areas such as forensics, nutrition sciences, agriculture, and veterinary sciences to drive growth.--BEGIN PROMO--

Research Highlights

This study highlights the prominence of qPCR and dPCR globally, growth opportunities, competitive dynamics, regional assessment, as well as novel business models.


  • The qPCR instrument segment has matured with manufacturers competing on the basis of factors such as pricing, ease of use, and accuracy. Manufacturers are offering capabilities such as multiplexing and modular capabilities—to seamlessly fit into the wider automated lab ecosystem—as users look to improve process efficiencies and control cost.
  • The PCR reagent segment emerges as the segment with the largest revenue driven by high consumption across device types. With improvements in instrument technology, reagents are also expected to innovate. For example, companies need to provide multiplexing-capable reagents kits that offer higher speed, efficacy, and lower processing time for multiple indications. Additionally, consumers demand custom as well as dry kits with primers and probes for specific targets.
  • While the dPCR instrument segment shows the fastest growth rate during our forecast range of 2018-2023, the high initial cost of the dPCR instrument continues to be a significant roadblock for its adoption with most users commenting that current qPCR devices are adequate to cater to their needs. However, manufacturers are driving usage in areas that require exact quantification capabilities and comparatively higher detection sensitivity, such as liquid biopsy. Companies are also launching dPCR instruments that attempt to mimic the high throughput capabilities of traditional qPCR instruments.
  • PCR software are used across the PCR processing value chain including primer design, sample preparation, process management, as well as final result analysis. While device manufacturers provide the software, a variety of independent software platforms are available as well. Software vendors are offering value-add capabilities such as laboratory information management system (LIMS) connectivity and transfer, data management, and auditing capabilities. Companies such as UgenTec offer an AI-powered automated solutions for analysis of high-volume PCR data to reduce the need of human intervention.

Companies such as Thermo Fisher, Bio-Rad, Roche, Qiagen, and Agilent emerge as leading players in the qPCR as well as the reagents segments. However, the reagents segment is highly fragmented towards the tail end as many devices can run reagents/kits from multiple manufacturers and users tend to use reagents/kits as per their personal criteria. The dPCR instrument segment shows the fastest growth, with Bio-Rad and Thermo Fisher emerging as leading companies in this space.

Areas of opportunities:

  • PCR application in Liquid Biopsy: Liquid biopsy techniques for tumor profiling and treatment monitoring applications using biomarkers comprising circulating tumor DNA (ctDNA) are likely to be an emerging application area
  • AI to Automate PCR Processes and Analysis: Wide use of PCR is creating huge data sets, hence high-volume labs are looking for solutions that can automate the process as well as help in the management and analysis of data.
  • Companion Diagnostics (CDx) and Precision Medicine: Novel PCR methodologies such as dPCR can offer accuracy and reproducibility— key for correct prognosis and diagnosis in precise CDx solutions.
  • Multiplexing and Miniaturization: With high cost of lab consumables, multiplexing helps in running multiple processes simultaneously, whereas miniaturized devices help widen device and solutions access at lower costs.
  • Novel Application and Methodologies: Novel detection procedures, combination methodologies, as well as non-traditional areas of application are likely to drive growth in areas such as forensics, nutrition sciences, agriculture, and veterinary sciences.


Traditional growth markets such as the United States and Europe have matured and growth is expected to be driven by novel instrument and reagent technologies, as well as from the use of automated modular systems. Developing regions such as APAC and LATAM are expected to be the next growth engines with increasing research and healthcare spending in key countries in the region. However, each country in these regions may differ significantly in their market requirements and may require a bespoke approach combining factors such as widening of sales channels, developing robust service networks, and customized product portfolios.

Key Issues Addressed

  • What is the market size and growth forecast for the qPCR and dPCR segments?
  • Who are the key competitors in this market? How does the competitive landscape look like?
  • What are the key growth opportunities for existing companies and new entrants in this market segment?
  • What changes to the business model are required from companies to cater to changes in market conditions?
  • How is the PCR market evolving? What has been driving M&As in this industry?
  • What are the opportunities and challenges in the high-growth regions?


Mon, 14 Jan 2019 00:00:00 +0000
Integrated Practice Management Software (IPMS) Market Primary Care IT 2.0 in Europe, Forecast to 2022 There is a high demand for more efficiency of time and resources in General Physician (GP) practices that are extremely strained under the increasing chronic disease burden and decreasing staff numbers. There is also increasing reliance on healthcare information technology, driven by a supportive regulatory environment, and it is contributing to a need to upgrade systems across primary healthcare for efficient functioning which is augmenting market growth. Across Europe, basic primary care IT is well established, but is limited to patient administration and healthcare information management at a practice level. With the rise of integrated care models, the role of primary care in the healthcare ecosystem is much more than that of a gatekeeper and to meet the demand, practices will have to look at solutions that can manage and share information within and outside the network; thereby, requiring integrated practice management software.--BEGIN PROMO--

Research Highlights

The study identifies opportunities by country and for all the different ecosystem components, especially for:

  • Value-based Care: improving performance assessment tools in primary care
  • Social Prescribing: Increasing role of GP practices in integrated and community care
  • Relationship Continuity: GPs to play an increasingly important part in patient-centric care
  • Retail Health: rise of walk-in clinics and community pharmacies as a part of primary care

Key Features

The objective of this research study is understanding the emerging concept of integrated practice management software and its adoption in primary care centers in Europe. Integrated practice management software is an end-to-end solution that offers clinical, administrative, and billing functions. With integrated EHR capabilities, these solutions offer functionalities, including ePrescription, scheduling, appointment systems, and portals for messaging as well as billing. Such solutions are an advancement over practice management systems that were primarily focusing on the billing & administrative function (particularly patient scheduling). The addressable market includes primary care centers operated by solo or group GP practices. This research study does not cover outpatients centers and ambulatory care units that are affiliated to hospitals. Countries covered for market forecast are the UK, France, Germany, Spain, Italy, Scandinavia, and Benelux. The study also discusses the emerging market in Estonia, Poland, and Austria qualitatively.

Key Issues Addressed

  • What is integrated practice management software? What has driven the development of these IT solutions?
  • How is the adoption of IT in primary care evolving? What is the impact and adoption of new technologies?
  • How are the initiatives at the national and regional level for driving adoption of integrated practice management software?
  • What is the current vendor landscape for integrated practice management software in Europe and how is it expected to evolve over the next five years?
  • What are the most promising growth opportunities and key investment areas over the next 5 years?

Author: Chandni Mathur


Fri, 11 Jan 2019 00:00:00 +0000
Growth Opportunities in Precision Medical Imaging, Forecast to 2022 The precision medicine paradigm has found its early roots in genetic profiling, as genomics have proven their potential in helping clinicians decide on the right treatment for the right patient at the right time. Not far behind is medical imaging, which is rapidly developing its own, image-based approaches to tailoring decisions and care pathways to individual patients. Indeed, as one of only four ways to phenotype a patient, together with clinical history through physical examination, lab testing, and pathology diagnostic imaging provides a fundamental source of information for personalized medicine. At every step of the medical imaging value chain, opportunities are developing for a personalized approach to imaging, away from a one-size fits-all model: from ordering and planning imaging studies, to imaging equipment advances and personalized image acquisitions, to precision reporting and image analysis with quantitative imaging biomarkers and radiomics, to image-based 3D printing and real-time image-guided interventions and therapies, to high-precision radiation therapy and molecular imaging of theranostic radiotracers, and with the overarching analytics layer that closed the loop on imaging's value, quality and outcomes. Precision imaging s impact is expected across the key clinical application areas of oncology, metabolic diseases and neurological disorders, and the paradigm itself is expected to result from the convergence of several developments, including but not limited to integrated and structured big imaging datasets, multi-modal techniques in multidisciplinary care, and personalization under a consumerist paradigm. Every major economy has launched wide-scale precision medicine projects over the last few years, involving genetic profiling of millions of people. Medical imaging is now the next in line, as the interest in imaging biobanks and registries and the confidence in image-based cohort creation and therapy selection and planning are growing rapidly. While all of the major imaging companies have taken notice of the "precision imaging" opportunity, their respective approaches and proactive levels vary widely.--BEGIN PROMO--

Research Highlights

This study attempts to define the role of medical imaging in the precision medicine paradigm, outlines reasons of why investing in this area is beneficial, sizes the potential of this market opportunity, and identifies the ten crucial growth opportunities in this space, along with representative examples for each opportunity. These growth opportunities are mapped to the stages of the imaging care continuum – study ordering, image acquisition, image interpretation, image-based intervention, therapeutic dose radiation, and study impact evaluation.

Key Issues Addressed

  • Image-based inferencing for precision medicine: what is the current state-of-play?
  • What are the key applications and use cases, and how fast are they developing?
  • What is the size of the market opportunity overall, and the growth projection?
  • What are the top 10 main levers of growth-creating new market opportunities?
  • What are some interesting examples from innovative companies within each precision imaging segment?

Author: Siddharth Shah

Wed, 9 Jan 2019 00:00:00 +0000
Innovations in Hemostatic Wound Dressing, Smart Inhalers, Cardiac Rehabilitation, Patient Engagement, Myoelectric Orthotics, and Hybrid Imaging The latest issue of Advanced MedTech TOE profiles innovations spanning the breadth of the medical technologies industry. Some of these innovations have been sourced from the digital health space, such as a patient engagement platform to optimize clinical outcomes, and an Internet-delivered cognitive behavioral therapy solution. Other innovations include a hemostatic wound care product, smart inhalers, and tissue ablation solutions. This edition also profiles the novel use of artificial intelligence algorithms for medical imaging and diagnosis. innovations spanning the breadth of the medical technologies industry. Some of these innovations have been sourced from the digital health space, such as a patient engagement platform to optimize clinical outcomes, and an internet-delivered cognitive behavioral therapy solution, there are innovations include hemostatic wound care product, smart inhalers and tissue ablation solutions. This edition also profiles the novel use of artificial intelligence algorithms for medical imaging and diagnosis.. The Advanced MedTech TechVision Opportunity Engine (TOE) analyzes and reports new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, ultrasound, X-ray, neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Hemostatic wound dressing, hybrid imaging, digital health, smart inhalers, artificial intelligence, ultrasound imaging Fri, 4 Jan 2019 00:00:00 +0000 Technologies with High Funding: Impact Assessment and Growth Opportunities This report "Technologies with High Funding: Impact Assessment and Growth Opportunities" focuses on recent technologies with high funding. It analyses the impact and growth opportunities for these technologies in ICT, healthcare, chemicals and materials, sensors, advanced manufacturing, energy, and environment. The high funding technologies covered are Artificial Intelligence, Artificial Organs, Big Data, Biomarker Analytics, Distributed Energy Generation, LiDAR, Metal 3D printing, Nanohybrids, and Smart Water Grid. Mon, 31 Dec 2018 00:00:00 +0000 Robotic Exoskeletons: Roadmapping and Impact Analysis Awareness and research initiatives of robotics technologies improving human life and intelligence have created opportunities for robotic exoskeleton manufacturers to discover a wide range of applications across various sectors. Efficient human-robot interaction, reduced footprint, ease of integration, reprogram ability and creation of flexible environment are encouraging advancements of robotic exoskeletons. Robotic platforms are expected to be pivotal role in automation. Apart from automating the working environment, the adoption of exoskeletons will ease the tasks of humans associated with dangerous and hazardous tasks. In healthcare industry, robotic exoskeletons are expected to play a quintessential role in offering effective physical rehabilitation and elderly care solutions. The scope of this report is limited to robotic exoskeletons based on its applicability in healthcare, manufacturing, military and construction sector. This technology and innovation report focuses on providing a snapshot on the key impact of exoskeletons on sector level, social and economic front. A global patent and funding assessment on the technology development is included in the report along with key innovations and growth opportunities of robotic exoskeletons. A global analysis on the current development of robotic exoskeleton technologies was done to assess the disruptive opportunities of exoskeletons. Key questions addressed in the research service: What are the key emerging applications which will have a high impact in the adoption of robotic exoskeletons? What are the benefits and challenges of robotic exoskeletons? What are the key innovations impacting technology development? What are they patent trends witnessed in the robotic exoskeleton area? What are the key focus areas of technology development? What are future growth opportunities? Mon, 31 Dec 2018 00:00:00 +0000 Disruptive Innovations in Natural Colors Consumer demand for naturally derived ingredients and raw materials have led to the increasing demand for natural colors in various industries, the foremost being the food and beverage (F&B) industry. Currently, a major trend in the industry is the clean label trend that is being actively pursued by ingredient manufacturers and product developers alike. The clean label tag helps in gaining consumer confidence and create a perception of health and wellness in various food and beverage products. While the use of natural colors is able to overcome the possible adverse effects of artificial colorants, the use of natural colorants is still considered to be in emerging stages mainly due to challenges related to stability, possible leaching and scaling. Efforts to overcome these challenges and development of natural colorants that can impart additional functional benefits are key areas of focus by both academia and industry alike. Besides the ability to develop colorants for use in a wide range of applications, technology developers are also focusing on improving cost-effectiveness to hasten wide scale adoption. This research service titled Disruptive Innovations in Natural Colors discusses the recent developments in the natural colors that are being touted as a viable alternative for synthetic and chemical ones. The research study focuses primarily of the innovations targeted towards the F&B industry, being the most research intensive application for natural colors. In brief, the research study captures the following: Overview of natural colors and application segmentation. Assessment of key innovations, research focus areas and technology developments Key impact factors that influence acceptance of natural colors by consumers Emerging opportunities for technology developers Key patents. both granted and application status Sat, 29 Dec 2018 00:00:00 +0000 Digital Pathology: Roadmap to the Future of Medical Diagnosis Digital Pathology encompasses the use of optmized pathology workstations, whole slide imaging, image analysis, image management, laboratory information management system, use of machine learning, data handling and storage. Pathology is one of the most important fields in medicine, as the service provides investigation and validation platform in lieu of a medical condition of a patient. Traditional methods of pathology involves slide preparation, traditional microscopy, result interpretation from microscopy by pathologist onto an information management system followed by physical storage of slides for a prescribed timeline. According to numerous research and surveys conducted across the world, the request for pathology services are increasing by a healthy percentage year-on-year which can be attributed to the increase in cancer prevalence across the globe, ageing population amongst a number of other factors. Factoring in to the above the number of experienced pathologists available at the moment and ones about to retire, the scenario for pathology services may start to look grim. Therefore, an urgent solution is needed to tackle the challenges pertaining increase in diagnosis of patients and unreasonable timelines that pathologists are facing currently with the traditional pathology methods. Proper deployment of Digital Pathology solutions have the demonstrated ability to streamline the workflow of pathology services, and can potentially increase the efficiency of the workflow and decrease the time for diagnosis. Artificial Intelligence (AI), Machine learning and deep learning are terms that refer to the technology that possesses the ability to recognize patterns from the database that it is initially provided with and matching to it to similar data set thus mapping the results based on past occurrences. The use of AI in digital pathology has gained momentum over the last few years. Notably, the FDA approved an AI-tool as a primary diagnosis tool as recently as in 2017 for wrist fractures. The application of AI for pathology services are innumerable considering the fact the pathological services give rise to a lot of information. Information or data sets that can serve as the basis of creating deep learning digital pathology tools that can act as a diagnosis supplement tool for pathologists, thus increasing the speed of diagnosis, maybe accuracy and certainly providing the potential to prioritize diagnosis cases based on severity for the pathologists to review. The next decade of the medical field is set to witness the transformation of digital pathology services by AI tools. Sat, 29 Dec 2018 00:00:00 +0000 RNA Technologies Enabling Drug Discovery and Development This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: Industry Drivers and Challenges Technology Snapshot and Trends Clinical Pipeline Analysis Overview of the IP Landscape Innovator Profiles Future Roadmap The RNA therapy platforms covered include: Splice-Switching Oligonucletides (SSO) Other Anti-Sense Oligonucleotide (ASO) Aptamers RNA-interference mRNA saRNA An appendix is included, comprising lists of major industry influencers found in the study. Fri, 28 Dec 2018 00:00:00 +0000 Incisionless Surgeries: Envisioning The Future of Surgical Technology The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer. Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical outcomes and costs associated with such incisionless procedures. This research service focuses on various technologies that enable hospitals to maximize the value of incisionless surgeries prescribed to patients (especially old age and critical cases), while achieving an optimal balance on the volume of procedures performed within the same premises. The first section focuses on the current industry snapshot and segmentation of the global incisionless surgeries market. The section outlines the supplier landscape, major end-user segments and products that cater to various clinical applications. The section also brings out the critical growth factors that differentiate competitive performance and outlines the key R&PD initiatives that are necessary to achieve optimal balance between procedural volumes and value. The second section focuses on the critical technology success factors that are necessary for hospitals to improve the value of incisionless surgeries, while optimizing their procedural volumes critical to meet revenue and business performance. The section also uncovers technology factors that are critical to retaining or enhancing procedural volumes, focusing on improved turnaround time, efficient OR use and reduced costs of laparopscopic procedures such as use of handheld microsurgical instruments. The third section focuses on the prioritization of technology factors that contribute to procedural volumes and value, which demonstrate an optimal balance between supply of such technologies to meet the existing demand. The section also uncovers the critical business models that enable hospitals achieve their targets fixed for procedural value and volumes for various customer segments and regions. Fri, 28 Dec 2018 00:00:00 +0000 Disruptive Innovations Redesigning Orthopedic Devices and Procedures Orthopedic procedures spans the spectrum from diagnosis to surgery, from implants to exoskeleton devices, and from a technology perspective, from biomaterials to digital innovations improving orthopedic outcome. TechVision's latest research service provides an overview of the innovations that are propelling the orthopedics industry along devices, implants, procedures and surgical solutions. This research service showcases major technical innovations, an overview of the IP landscape and opportunities for stakeholders to leverage market opportunities Fri, 28 Dec 2018 00:00:00 +0000 Metal 3D Printing Revolutionizing Modern Manufacturing Metal 3D printing has experienced increased demand in the additive manufacturing market. However, the high cost of printers, slow speed, and limited part size have somewhat limited the volume opportunities for metal 3D printers in industrial applications. The rapidly evolving manufacturing industry has recognized the significance of additive manufacturing technology and has initiated R&D projects and set up dedicated teams to further improve and expand the technology capabilities to meet future end-user needs. The metal 3D printing market is becoming one of the fastest growing market segments in the digital era, and the trend is expected to continue moving forward. The focus of 3D printing has moved from hobbyist to industrial and business applications with metal 3D printing in the limelight at present. While plastic 3D printing technology using 3D printing techniques, such as fused deposition modeling (FDM) is the largest market segment, metal 3D printing is gaining attention. The growing demand for metal 3D printing is highly driven by the ability of the technology to manufacture highly customized metal alloys at affordable prices and the ability to combine various separate parts into a single unit. Key applications include: aerospace, automotive and healthcare industries.--BEGIN PROMO--

Key questions answered in the study:

• What is the significance of metal 3D printing?

• What are the key funding trends and focus areas?

• What are the manufacturing innovations driving adoption?

• How do end-users leverage the benefit of metal 3DP?

• What are the growth opportunities beyond 2020?

• What is the future of metal 3D Printing?

Fri, 28 Dec 2018 00:00:00 +0000
Microbiome Technologies Fueling Human Health and Wellness This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic competitive landscape Food & Beverages This research segment evaluates the role of microbiome technologies fueling improving F&B products, while providing an analysis of the innovative and evolving F&B landscape Personal Care Microbiome technologies has had a significant impact across the global skincare industry, and this research segment analysis the key technologies impacting the personal care space, while highlighting some of the key industry participants across each technology segment. Indoor Air Quality This is the newest sector to have been impacted by developments across the microbiome landscape. This research service evaluates some of the key developments fueling to enhance the microbiome balance within indoor settings. Thu, 27 Dec 2018 00:00:00 +0000 Global Healthcare Market Outlook, 2019 Globally, 2019 will be a year of value-based care, as outcome-based care focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in emerging markets such as Asia, Africa, and Central and Eastern European countries. Future drugs and devices R&D investments will be more targeted to meet the unique needs of emerging markets. As the lines between retail, IT, and healthcare markets continue to blur, digital marketplace providers such as Amazon will dominate the home health space, but will find it difficult to compete in the traditional B2B hospital/providers space dominated by established participants. Non-traditional participants such as Amazon, Ali Health, Microsoft, and IBM with digital technologies will provide the required impetus to public health systems to ensure accessibility and affordability of care. During 2019, digital health will start to come of age favorable reimbursement policies toward clinically relevant digital health applications will expand care delivery models beyond physical medicine to include behavioral health, digital wellness therapies, dentistry, nutrition, and prescription management.--BEGIN PROMO--

Research Scope

In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare market in 2019. The sectors covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for the upcoming year. The study provides guidance on where to find the greatest opportunities for expansion.

Key Features

Predictions for the global healthcare market in 2019 include:

  • Value-based care progressing globally
  • Artificial Intelligence (AI) exploding across the healthcare and life sciences ecosystem post flagship level use cases yielding positive results
  • Digital health coming of age with increased focus on individual care
  • Asia becoming the new local innovation hub for global drug and device OEMs
  • Healthcare data analytics focus shifting from Big Data to meaningful small data by hospital specialty
  • Healthcare to be a dominant vertical in voice applications as HIPAA-compliant voice and chatbot applications for healthcare gain prominence
  • Blockchain move from hype to reality with initial commercial implementations across focused B2B enterprise blockchain applications
  • Innovative private insurance models shaking up the healthcare payer market

Key Issues Addressed

  • What are the top predictions for healthcare markets in 2018?
  • What are the market revenues and growth rates expected for the global healthcare market?
  • What are the key projections and growth opportunities for major healthcare market segments?
  • What are the major macro and micro-regional/country-level trends specific to the healthcare market?
  • What are the key technologies and growth opportunities to watch out for during 2018?

Author: Kamaljit Behara

Wed, 26 Dec 2018 00:00:00 +0000
Micro- and Nano- encapsulation: Technology Impact Analysis Encapsulation is used to preserve/protect various substances within another material at microscale sizes (microencapsulation) and at nanoscale sizes (nanoencapsulation). The material encapsulated is referred to as the core whereas the encapsulates is referred to as the shell . The core material for different nanocapsules differs in size, shape and composition. Encapsulation is performed to achieve specific objectives and functionalities such as targeted delivery, sustained release etc. The need to improve the stability of active ingredients and prevent degradation of the same due to environmental conditions would be the key factors enabling growth of encapsulation. Both micro-, and nano-encapsulation technologies would be predominant in all areas wherein protection and stability of the active ingredient is the key; prominent being personal care, food, and healthcare sectors. Micro-encapsulation is mostly aimed at colloidal and surface properties that provide protection against environment and provides control to the release characteristics of different coated materials while nano-encapsulation exhibits potential to enhance bioavailability, improve controlled release, and enable precision targeting of the bioactive compounds. This research service titled, Micro- and Nano-encapsulation Technology Impact Analysis analyzes the potential of the technology across various applications. In brief, the research study provides: An overview of various micro- and nano-encapsulation technologies. A highlight of various application segments and trends that influence adoption. An analysis of the key factors that influence adoption of micro- and nano-encapsulation amongst various industries. An assessment of various technology developments and industry initiatives. A patent filing trend analysis highlighting key patents, both granted and in application status related to micro- and nano-encapsulation New developmental aspects and future prospects for development and adoption of micro- and nano-encapsulation technologies. Mon, 24 Dec 2018 00:00:00 +0000 Applications of Advanced Visualization in Healthcare This edition of Future Tech TOE covers features advanced visualization techniques and their application in the healthcare industry. Comparing the current limitations in medical visualization and the changing nature of healthcare data, these visualization tools will deliver greater value to the physicians and the patients. Augmented and virtual reality tools have found adoption in entertainment and gaming, and the healthcare industry is set for bigger adoption. Some of the segments that get a value addition through advanced visualization include dentistry, surgery, and physical and mental rehabilitation. The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profiles existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world. The Chemicals and Advanced Materials cluster tracks research & innovation trends and developments across specialty chemicals, plastics, polymers, chemicals, bio-chemicals, metals, coatings, thin films, surface treatments, composites, alloys, oil and gas, fuel additives, fibers and several other related technologies and its impact and application across industries. Keywords: Augmented reality, virtual reality, mixed reality, surgery, physical rehabilitation, cognitive rehabilitation Fri, 21 Dec 2018 00:00:00 +0000 Innovations in Preventive Health Monitoring, Imaging Systems, and Personal Assist Devices The latest issue of Advanced MedTech TOE presents a broad coverage of the healthcare industry, featuring innovations pertaining to maternal and fetal health, pain management, artificial pancreas for diabetes management, and cardiovascular disease diagnosis. An important feature of this issue is also the presence of a number of digital health innovations such as, a smart watch for epilepsy management, the use of AI for preventative health, and smartphone-powered defibrillator. These innovations have been sourced from around the globe and are in various stages of technology maturity, offering industry stakeholders plenty of business opportunities. The Advanced MedTech TechVision Opportunity Engine (TOE) analyzes and reports new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, ultrasound, X-ray, neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Digital health, artificial pancreas, smart watch, preventative health, maternal health, pain management, neuromodulation Fri, 14 Dec 2018 00:00:00 +0000 Growth Opportunities in Functional Consumables Aftermarket, Forecast to 2023 Rapid technological turnaround has become a norm in the life science and in-vitro diagnostic industry. Extrinsic factors such as lack of skilled labor to operate the instrumentation as well as functional factors like demand for very high precision and reproducibility of results are driving this technological evolution. As the instrument efficiency goes on increasing, the aftermarket for instruments will gain four to five times the value of the original equipment manufacturing market in the next ten years. Even though this space is dominated by a handful of very large participants like Thermo Fisher and Perkin Elmer, there has been measurable growth of small- to medium-sized participants in the last five years. A shift in competitive factors from delivering end-to-end product portfolio to providing high-value super-specialized innovation is witnessed. Although there is an evident overlap in the product offerings to research labs and commercial reference labs, a remarkable difference in the purchasing patterns and product lifecycle management has been observed. This research study covers the shifting dynamics between end users and an accelerating trend in consolidation, influencing the purchasing trends. The study also captures the additional play between different value chain participants like the OEMs and CMOs and rising trend in outsourcing. While there has been exponential growth in demand for diagnostic services, there is a constant pressure to do so under budget and skill constraints. This has led to rise of new technologies that are not only pushing the envelope on sensitive, rapid, and accurate testing but are also affordable in terms of reducing the cost of total treatment cycle. This study identifies some of the key technology trends empowered by innovation in functional consumables and growth opportunities, which are set to drive the market in the next five years. In conjunction with technological evolution, the study highlights new and emerging business models that have enabled certain companies to succeed in this incrementally competitive market. It also gives an overview of the competitive environment, providing brief insights on some of the game-changing participants as well as emerging participants, which have the potential to unlock growth in this market. Germination of innovation continues to remain fragmented but larger participants have managed to bring them together on a common platform to create integrated sub-assemblies. Therefore, the focus is also given on some of the leading M&A activities impacting the market as well as present and future market trends that would shape the market. Acknowledging the ongoing trends in consumerism pervasive across B2B as well as B2C channels, the study lays down strategic imperatives for successful go-to-market strategy. Lastly, the study also captures threats from sensor-based technologies to existing cadre of disposable functional consumables and more noticeably opportunities in circumventing the threat through collaborative growth. This research service also provides in-depth revenue and geographical market analysis of 3 key market regions, EU5, North America, and Asia-Pacific, identifying purchasing trends and technological demands in each region.--BEGIN PROMO--

Key Issues Addressed

  • What are the biggest opportunities for companies in clinical diagnostic consumables space?
  • How are the various regions around the globe positioned to monetize the market opportunities? What are the key regional barriers to entry?
  • How are the business models evolving across the value chain and impacting the different stakeholders?
  • What is the total market size and projected growth of functional consumables market?
  • How product offerings in this market are likely to emerge? What is the rate of innovation adoption and how is it solving the unmet needs of customers?
  • Which are the key game-changing companies in the segment and how are they riding the growth curve?

Author: Khushbu Jain

Wed, 12 Dec 2018 00:00:00 +0000
Latest Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms. Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as quantum computing in life sciences, innovations in drug delivery, and novel investigational therapies for diabetes and other disorders. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Quantum computing, nanoscale imaging, quantum machine learning, gene regulation, quantum sequencing, high-throughput quantum mechanics, JAK1 inhibitor, asthma, gene silencing, hepatitis B infection, diabetes, stem cells, cluster headaches, osteoarthritis, thymocyte signaling, autoimmune disorders, Helicobacter Pylori, tumor imaging Fri, 7 Dec 2018 00:00:00 +0000 The Future of Patient Engagement 2.0 in Europe, 2018 Healthcare today is not about just going to the doctor at the time of illness or on regular appointments to check the overall disease progression. It is shifting to a more proactive rather than reactive approach with patients being more aware and willing to be involved in their own health. The traditional culture of healthcare and how people engage in healthcare is being dramatically reshaped by new cultural attitudes and the pervasive adoption of mobile phones/smartphones/social media by the general population as well as digital health tools increasingly used by healthcare providers. This opens up new possibilities for reshaping behaviors, especially for younger demographics. Further, health systems around the world are reeling under the pressure of rising costs, shortage of personnel, and the ever-increasing burden of chronic ailments. Digital health solutions are the saviors in such a landscape driving Patient Engagement 2.0. Not only do the IT solutions empower the patients, they also provide a cost-effective alternate channel for managing chronic patients. Broadly, digital health solutions cater to patient touch points across the care continuum and target clinical (remote monitoring, telehealth etc.), administrative (appointment scheduling, reminders etc.), and financial (billing, payer communications etc.) functions. A plethora of pure-play patient engagement companies are offering innovative solutions. EHR providers and medical device companies are not far behind. Different vendor types are targeting different gaps in the care journey. Innovations and start-up activity is abundant in this area with trends such as healthcare consumerization shaping up. Increasingly, there is a demand for clinical-grade digital solutions which offer the ease of use of consumer-grade devices and the accuracy and efficacy of medical-grade ones. Europe is emerging as a strong market with some countries becoming more attractive for such solutions. The regulatory framework of countries, IT infrastructure, and sociocultural factors have a major impact on the uptake of patient engagement solutions. The value of engaging patients digitally is not just being seen among the healthcare providers, but also with medical diagnostics, devices, pharmaceuticals, and insurance providers. As the report title reads, There is something for everyone . The stakeholders of the healthcare ecosystem should not look at patient engagement as a one-time activity, but as a cultural shift in the change of mind set and way of life. This report covers the current scenario for patient engagement in Europe and among stakeholders and also delves into growth opportunity areas for vendors to exploit in the next five years. Author: Chandni Mathur Fri, 30 Nov 2018 00:00:00 +0000 Hybrid Manufacturing: Technology Roadmapping and Opportunities Rapid proliferation of three-dimensional (3D) printing technology in the industrial arena has attracted manufacturers and consumers to adopt the technology widely. Also awareness of the technology has led to the innovative option of merging additive and subtractive additive manufacturing techniques. The hybrid manufacturing technique or system often comprises direct energy deposition, powder bed fusion and milling techniques. Addition of milling option to additive manufacturing provides high quality products with improved surface finish, thus resulting in improvised solutions for design engineers. The technical attributes of hybrid manufacturing overhaul existing conventional techniques and have created footprint in sectors such as oil and gas, aerospace, and automotive. Business models are also evolving toward leasing of machinery, providing hybrid systems as a service in the manufacturing arena. This will increase the bandwidth of industries that the hybrid manufacturing systems service. Aerospace is one of the major industries impacted by the introduction of hybrid 3D printers. The technology is expected to improve tolerances, geometrics, and surface areas. 3D printing itself can enable production of lightweight components. 3D printed metal parts can reduce the weight of an airplane by about 7%. The technology and innovation report assesses opportunities for hybrid manufacturing systems, and provides insights on technology development scenario for the near-, medium-, and long-term. Growth opportunities for hybrid systems in different applications are also assessed. The technology and innovation report addresses the following questions: a) What is the significance and attractiveness of hybrid manufacturing technology? b) What are the key factors influencing adoption of hybrid systems over conventional techniques? c) What are the market potential and key trends impacting opportunities? d) How does research and patent scenario impact development? e) Who are the major companies working in hybrid manufacturing and what is the impact of their development? f) What will be the technology development scenario in the near-, medium-, and long- term and related growth opportunities? Tue, 20 Nov 2018 00:00:00 +0000